| buy jordan 1 Retro 8/2(日) 05:26:40 No.20150802052640
Subject to FDA approval, the Company projects market launch in 2017Complete enrollment in the ongoing Phase 1b clinical trial with combination of aldoxorubicin and ifosfamide/mesna as first line treatment for advanced sarcomas by the third quarter of 2015 and initiate a Phase 2 study with that
|
|